2012
DOI: 10.1021/nn302538y
|View full text |Cite
|
Sign up to set email alerts
|

Hyaluronic Acid–Gold Nanoparticle/Interferon α Complex for Targeted Treatment of Hepatitis C Virus Infection

Abstract: Gold nanoparticles (AuNPs) have been extensively investigated as an emerging delivery carrier of various biopharmaceuticals. Instead of nonspecific polyethylene glycol (PEG) conjugated interferon α (IFNα) for the clinical treatment of hepatitis C virus (HCV) infection, in this work, a target-specific long-acting delivery system of IFNα was successfully developed using the hybrid materials of AuNP and hyaluronic acid (HA). The HA-AuNP/IFNα complex was prepared by chemical binding of thiolated HA and physical bi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
120
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 148 publications
(126 citation statements)
references
References 34 publications
5
120
0
Order By: Relevance
“…There are also examples from the literature where multivalent conjugation to HyA has been shown to maintain an effective serum concentration of protein-based drugs after systemic administration, 79,80 yielding an improvement in their pharmacokinetics that was comparable to PEGyation. 81 By contrast, in this study, we applied the mvShh treatments locally and were unable to separate the multivalency advantage from any other in vivo advantages of conjugation to a long-chain biopolymer.…”
Section: Discussionmentioning
confidence: 76%
“…There are also examples from the literature where multivalent conjugation to HyA has been shown to maintain an effective serum concentration of protein-based drugs after systemic administration, 79,80 yielding an improvement in their pharmacokinetics that was comparable to PEGyation. 81 By contrast, in this study, we applied the mvShh treatments locally and were unable to separate the multivalency advantage from any other in vivo advantages of conjugation to a long-chain biopolymer.…”
Section: Discussionmentioning
confidence: 76%
“…As a target-specific drug delivery carrier, HA has been investigated well in the HA receptor-mediated endocytosis because of its polyanionic characteristics and hydrophilicity, 32 and highly efficient targeted delivery to target sites with HA receptors, such as CD44, HARE, and LYVE-1, for various biological functions. 33,34 According to over-mentioned intensive reports, we chose HA as a targeting ligand to synthesize the HA-Bi 2 O 3 NPs as a multifunctional theranostic platform that can afford spatialand temporal-specific CT imaging and enable overcoming cancer radioresistance. This specifically developed tumortargeted probe holds a great promise as a CT imaging CA with better CT imaging quality at reduced CA dosage when compared with the currently available CAs imaged using a clinical CT scanner.…”
Section: Introductionmentioning
confidence: 99%
“…HA-IFN-GNPs of 22 nm showed preferential accumulation in liver and remained in the liver upto 7 days postinjection, as measured by 2´-5´ oligoadenylate synthetase expression. As compared with IFN-GNPs, greater therapeutic efficacy of HA-IFN-GNPS was found to be associated with enhanced serum stability of the later [61].…”
Section: Pullulan-based Nanoparticlesmentioning
confidence: 93%